ACH
ABMD

ArrowMark Colorado Holdings’s Abiomed Inc ABMD Stock Holding History

ArrowMark Colorado Holdings’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-128,085
Closed -$42.4M – 357
2022
Q1 		$42.4M Sell
128,085
-1,352
-1% -$416K 0.37% 81
2021
Q4 		$46.5M Sell
129,437
-1,345
-1% -$454K 0.37% 82
2021
Q3 		$42.6M Sell
130,782
-759
-0.6% -$257K 0.33% 87
2021
Q2 		$41.1M Sell
131,541
-322
-0.2% -$98.8K 0.31% 90
2021
Q1 		$42M Sell
131,863
-59,132
-31% -$18.9M 0.31% 85
2020
Q4 		$61.9M Buy
190,995
+15,302
+9% +$4.23M 0.48% 65
2020
Q3 		$48.7M Sell
175,693
-148,358
-46% -$42.7M 0.46% 64
2020
Q2 		$78.3M Buy
324,051
+28,138
+10% +$5.65M 0.81% 37
2020
Q1 		$43M Buy
295,913
+7,677
+3% +$1.27M 0.56% 61
2019
Q4 		$49.2M Buy
288,236
+71,054
+33% +$13.2M 0.44% 71
2019
Q3 		$38.6M Buy
+217,182
New +$46.9M 0.39% 71
2018
Q2 		– Sell
-125,007
Closed -$36.4M – 356
2018
Q1 		$36.4M Sell
125,007
-39,753
-24% -$10.1M 0.36% 91
2017
Q4 		$30.9M Sell
164,760
-41,768
-20% -$7.8M 0.31% 95
2017
Q3 		$34.8M Sell
206,528
-1,147
-0.6% -$173K 0.4% 83
2017
Q2 		$29.8M Sell
207,675
-104,480
-33% -$14M 0.37% 87
2017
Q1 		$39.1M Buy
312,155
+79,613
+34% +$9.23M 0.53% 66
2016
Q4 		$26.2M Buy
232,542
+57,421
+33% +$6.65M 0.41% 81
2016
Q3 		$22.5M Sell
175,121
-115,243
-40% -$13.8M 0.41% 88
2016
Q2 		$31.7M Sell
290,364
-45,245
-13% -$4.5M 0.64% 53
2016
Q1 		$31.8M Buy
+335,609
New +$28.3M 0.71% 51

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ArrowMark Colorado Holdings's ABMD Position: Q2 2022 in Review

ArrowMark Colorado Holdings sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 128,085 shares — an estimated $42.4M sold.

ArrowMark Colorado Holdings first reported a position in ABMD in Q1 2016 and held it in 20 quarters. The position peaked at $78.3M in Q2 2020. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

  • ArrowMark Colorado Holdings reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
  • ArrowMark Colorado Holdings sold 128,085 Abiomed Inc shares in Q2 2022, an estimated $42.4M.
  • ArrowMark Colorado Holdings first reported a position in Abiomed Inc in Q1 2016 and held it in 20 quarters.
  • ArrowMark Colorado Holdings's Abiomed Inc position peaked at $78.3M in Q2 2020.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2022, filed 15 Aug 2022.